This post is also available in: Slovenščina

Hormonal-induced changes in haemostasis, fibrinolysis, blood flow, and the vessel wall
are the reasons why venous thromboembolisms are more common in pregnancy than
in non-pregnant women of the same age. The clinical presentation of venous thromboembolisms
is more unreliable than in non-pregnant women; an objective diagnosis should
be performed in suspected cases, and some peculiarities related to pregnancy should be
considered. Venous thromboembolism treatment in pregnancy is based on heparins,
preferably low-molecular-weight, while oral drugs (vitamin K antagonists and direct oral
inhibitors of coagulation) are contraindicated. Venous thromboembolism treatment should
last at least throughout the whole pregnancy and six weeks postpartum.